Avacta and Daewoong Pharmaceutical expand partnership to include COVID-19 neutralising Affimer therapy – Cambridge Network

Avacta Group plc (AIM: AVCT), the developer of Affimer biotherapeutics and reagents, is pleased to announce an expansion of its collaboration and licence agreement with Daewoong Pharmaceutical Co. Ltd. (KSX: 069620) and AffyXell Therapeutics, the joint venture established in South Korea by the two companies, to develop stem cell treatments incorporating Avactas neutralising Affimer therapy for the treatment of seriously ill patients with COVID-19 and to also prepare to rapidly develop similar therapies for future global pandemics

Read more
Impact of COVID-19 on Cell Freezing Media for Cell Therapy Market Overview with Detailed Analysis, Competitive Landscape & Forecast To 2026 -…

Innovative Report on Cell Freezing Media for Cell Therapy Market with Competitive Analysis, New Business Developments, and Top Companies A perfect mix of quantitative & qualitative Cell Freezing Media for Cell Therapy Market Market information highlighting developments, industry challenges that competitors are facing along with gaps and opportunities available and would trend in Cell Freezing Media for Cell Therapy Market. The study bridges the historical data from 2014 to 2019 and estimated until 2026. Prominent players profiled in the study: BioLife Solutions, Akron Biotechnology, GE Healthcare, Thermo Fisher Scientific, Biological Industries, Merck, WAK-Chemie Medical, Zenoaq Sample Report with Latest Industry Trends @https://www.acquiremarketresearch.com/sample-request/379423/ Covid-19 pandemic affects most industries in the globe

Read more
Unproven ‘stem cell’ therapies for COVID-19 pose harm to public, says UB expert – UB Now: News and views for UB faculty and staff – University at…

Be wary of stem cell therapy as a preventative treatment for COVID-19, warns Laertis Ikonomou, a UB expert on stem cell and gene therapies. While stem cell therapy, such as bone marrow transplantation, may be used to treat a limited number of diseases and conditions, there are currently no clinically tested or government-approved cell therapies available for the treatment or prevention of COVID-19, says Ikonomou, associate professor of oral biology in the School of Dental Medicine.

Read more
Global Cell Expansion Market, Forecast to 2025 – Increasing Incidence of Chronic Diseases and Government Investments for Cell-based Research -…

DUBLIN, July 30, 2020 /PRNewswire/ -- The "Cell Expansion Market by Product (Reagent, Media, Flow Cytometer, Centrifuge, Bioreactor), Cell Type (Human, Animal), Application (Regenerative Medicine & Stem Cell Research, Cancer & Cell-based Research), End-User, and Region - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering. The global cell expansion market is projected to reach USD 30.06 billion by 2025 from an estimated USD 14.91 billion in 2020, at a CAGR of 15.1%. The report segments the cell expansion market based on region (Asia Pacific, Europe, North America, and RoW), product (consumables and instruments), cell type (human cells and animal cells), application (regenerative medicine and stem cell research, cancer and cell-based research and other applications), and end user (research institutes, biotechnology and biopharmaceutical companies, cell banks, and other end users).

Read more
The function of the thymus and its impact on modern medicine – Science

How the thymus shaped immunology The function of the thymus was discovered by Jacques Miller in 1961 and laid a foundation for immunology and modern medicine. Until that time, researchers mistakenly believed the thymus merely represented a remnant of defunct lymph tissue, something of an immune cell graveyard. In a Review, Miller recounts the seminal experiments and conceptual thinking that led to uncovering the critical function of the thymus and provides insights that can be learned from those early days.

Read more